Your browser is no longer supported. Please, upgrade your browser.
NVO Novo Nordisk A/S daily Stock Chart
Novo Nordisk A/S
Index- P/E30.64 EPS (ttm)1.80 Insider Own- Shs Outstand2.05B Perf Week-1.78%
Market Cap113.07B Forward P/E24.03 EPS next Y2.30 Insider Trans- Shs Float1.42B Perf Month-7.85%
Income4.68B PEG1.86 EPS next Q0.47 Inst Own10.10% Short Float0.23% Perf Quarter-3.04%
Sales14.85B P/S7.61 EPS this Y7.90% Inst Trans2.01% Short Ratio2.54 Perf Half Y20.46%
Book/sh2.26 P/B24.41 EPS next Y13.61% ROA40.70% Target Price71.10 Perf Year25.64%
Cash/sh0.86 P/C64.16 EPS next 5Y16.50% ROE83.60% 52W Range41.08 - 60.34 Perf YTD32.38%
Dividend0.73 P/FCF42.00 EPS past 5Y23.10% ROI65.50% 52W High-9.99% Beta1.06
Dividend %1.32% Quick Ratio0.90 Sales past 5Y11.70% Gross Margin84.70% 52W Low32.22% ATR1.29
Employees39658 Current Ratio1.20 Sales Q/Q25.10% Oper. Margin42.10% RSI (14)42.76 Volatility1.49% 2.00%
OptionableYes Debt/Eq0.02 EPS Q/Q23.10% Profit Margin31.30% Rel Volume0.51 Prev Close55.16
ShortableYes LT Debt/Eq0.00 EarningsAug 06 BMO Payout42.80% Avg Volume1.30M Price54.31
Recom1.00 SMA20-3.47% SMA50-4.61% SMA2005.92% Volume667,045 Change-1.54%
Aug-28-15Initiated Leerink Partners Mkt Perform $56
Jun-09-15Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-15-15Initiated Societe Generale Sell
May-28-13Upgrade Deutsche Bank Sell → Hold
Mar-31-10Initiated Deutsche Bank Hold
Mar-30-10Downgrade Mehta Partners Outperform → Market Perform
Feb-24-10Upgrade Jefferies & Co Hold → Buy
Jan-15-10Downgrade Jefferies & Co Buy → Hold
Sep-11-09Initiated Jefferies & Co Buy
Aug-07-09Downgrade UBS Buy → Neutral
Aug-07-09Downgrade JP Morgan Overweight → Neutral
May-12-09Initiated Piper Jaffray Buy
Apr-24-09Upgrade Citigroup Hold → Buy
Mar-26-09Upgrade UBS Neutral → Buy
Jan-14-09Downgrade Citigroup Hold → Sell
Oct-06-08Upgrade Deutsche Securities Hold → Buy
Aug-29-08Downgrade Bernstein Mkt Perform → Underperform
Aug-21-08Initiated UBS Neutral
Jun-09-08Upgrade HSBC Securities Underweight → Neutral
Feb-26-08Downgrade Bear Stearns Outperform → Peer Perform
Sep-03-15 04:40PM  Bristol-Myers' (BMY) Opdivo Gets Priority Review, Shares Up
06:15AM  Research and Markets: China Insulin Detemir (Novo Nordisk) Market Report 2010-2019 Business Wire
Sep-02-15 04:30PM  Bristol-Myers/AbbVie Cancer Drug Gets Priority Review
Aug-31-15 08:47AM  Is Novo Nordisk (NVO) an Incredible Growth Stock? 3 Reasons Why It Will Be Tough to Beat
Aug-28-15 10:25AM  Now the work starts for Novo Nordisk in Clayton at
09:50AM  Research and Markets: China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk Business Wire
06:29AM  Coverage initiated on Novo Nordisk A/S by Leerink Partners
Aug-27-15 03:30PM  Novo Nordisk to Start PIONEER Program on Semaglutide
07:17AM  Effective obesity management: It's more than reducing numbers on the scale PR Newswire
07:17AM  Effective obesity management: It's more than reducing numbers on the scale CNW Group
Aug-26-15 02:13PM  Novo Nordisk adding diabetes drug output in NC, Denmark
01:50PM  Nearly 700 N.C. jobs announced as part of $1.2B Novo Nordisk expansion at
09:38AM  Emisphere Highlights Eligen Licensee Novo Nordisk's Entry Into Phase 3a Development of Oral Semaglutide, a Once Daily Oral GLP-1 GlobeNewswire
Aug-24-15 01:40PM  Novo Nordisk A/S Q2 Earnings Analysis: By the Numbers, 2015
Aug-14-15 03:21PM  Jim Simons Betting On Microsoft, Colgate-Palmolive, Novo Nordisk & Alaska Air
09:43AM  Novo May Benefit From Possible Shire-Baxalta Disruption at Bloomberg
04:58AM  Biggest Insulin Maker May Build Next Diabetes Drug Plant in U.S. at Bloomberg
Aug-11-15 04:13AM  Moody's: Accelerated growth expected for EMEA Pharmaceuticals in 2016 at Moody's
Aug-07-15 06:23PM  Novo Nordisk's Net Income Up Y/Y, 2015 Outlook Maintained - Analyst Blog
Aug-06-15 08:16AM  We want to be seen as Chinese: Novo Nordisk at CNBC
07:42AM  China gets tougher for Western drugmakers
07:06AM  Novo Nordisk points to tough China market at Financial Times
07:06AM  Novo Nordisk points to tough China market
05:45AM  Research and Markets: Investigation Report on China's Liraglutide Market, 2011-2019 Featuring Novo Nordisk Business Wire
Aug-05-15 09:12AM  4 Pharmaceutical Stocks to Buy in Wake of Shire-Baxalta Bid at TheStreet
Jul-30-15 06:23PM  Six International Leaders Preparing To Report Results at Investor's Business Daily
Jul-24-15 11:12AM  AbbVie: Beware the Biosimilars? at
10:14AM  Appointment Notice - Novo Nordisk Canada Inc. PR Newswire
10:14AM  Appointment Notice - Novo Nordisk Canada Inc. CNW Group
Jul-16-15 12:18PM  Novo Nordisk says Flexpro PenMate gets FDA approval Reuters
Jul-15-15 09:48AM  Greece Is On The Verge Of A Health Catastrophe at Forbes
Jul-13-15 01:50PM  Novo Nordisk Up on Positive Results from Diabetes Study - Analyst Blog
Jul-10-15 12:59PM  Novo Nordisk's new GLP-1 diabetes drug hits goal in trial +5.31%
Jul-07-15 03:50PM  Versartis (VSAR) Up on Partial Hold Lift on Lead Candidate - Analyst Blog
01:04PM  Is This Novo Nordisk's Next Blockbuster Drug? at Motley Fool
Jul-02-15 12:00PM  Novo Nordisk Halts Sale of Tresiba Insulin in Germany Over Pricing Dispute at The Wall Street Journal
Jul-01-15 12:15PM  The Greek debt crisis turned these European stocks into even better buys at Fortune
09:24AM  Status regarding Novo Nordisk's holding of its own shares (30 June 2015) Thomson Reuters ONE
Jun-29-15 04:45PM  Novartis' Cosentyx Positive in Psoriatic Arthritis Study - Analyst Blog
Jun-25-15 11:17AM  Conquering Hemophilia: Novo Nordisk Reports Encouraging Data From Phase III Trial Of NovoEight
Jun-24-15 06:15PM  Cramer: Getting down to BAX's Biz
Jun-22-15 03:17PM  Top Europe Stocks Rally On Greece Bailout Hopes at Investor's Business Daily
Jun-17-15 08:21PM  Edited Transcript of NOVO B.CO corporate analyst meeting
Jun-08-15 03:35PM  Novo Nordisk Reveals New Findings from Additional Studies - Analyst Blog
Jun-07-15 08:00AM  Novo Nordisk type 2 diabetes combo drug tops Sanofi's Lantus -study
03:00AM  New Xultophy┬« (IDegLira) Phase 3b Study Showed Statistically Significant HbA1c Reduction, Body Weight Change and Lower Rate of Hypoglycaemia Versus Insulin Glargine CNW Group
May-28-15 10:06AM  19 kids and cancelled: TV shows that got pulled due to controversy at Fortune
May-27-15 07:05PM  Is This Diabetes Stock a Better Bet Than MannKind? at Investopedia
May-25-15 12:50PM  Novo Nordisk's Saxenda Delays Onset of Type II Diabetes - Analyst Blog
May-20-15 12:08PM  Novo Nordisk, Baxter clash over haemophilia drug patent Reuters
10:52AM  Novo Nordisk rejects Baxter patent claim over Novoeight Reuters
10:40AM  China Diabetes Management Devices Market Growth to be Driven by Rise in Sedentary Lifestyle and Life Expectancy and Patient Compliant Technologies Especially for Insulin Pump and CGM PR Newswire
May-18-15 04:59PM  SLU vs. Bothell: The region's two hot biotech real estate markets go head to head at
May-17-15 11:36AM  Billionaire Jim Simons Top Holdings: Inc. (AMZN), Colgate-Palmolive Company and More at Insider Monkey
May-14-15 09:35AM  UnitedHealth Group (UNH), Novo Nordisk (NVO), Johnson & Johnson (JNJ): Cheapest Healthcare Stocks Picked By Markel Gayner at Insider Monkey
May-08-15 04:21PM  Healthcare Winners and Losers: May 8, 2015
May-06-15 06:00AM  Hot Drugs Show Sharp Price Hikes in Shadow Market
06:00AM  Diabetes Drugs Compete With Prices That Rise in Lockstep at Bloomberg
May-05-15 01:16PM  Healthcare Mid-Day Winners and Losers: May 05, 2015
12:51PM  Healthcare AM Winners and Losers: May 05, 2015
12:46PM  Healthcare AM Winners and Losers: May 04, 2015
12:46PM  Healthcare Mid-Day Winners and Losers: May 04, 2015
12:46PM  Healthcare Winners and Losers: May 04, 2015
May-04-15 03:41PM  Novo Nordisk (NVO) Beats on Q1 Earnings, Updates Outlook - Analyst Blog
May-03-15 11:28PM  Weekly 52-Week Highs Highlight: ALTR, AIG, LUX, NVO, EXPE
01:26PM  5 Trade Ideas for Monday: Fastenal, Goodyear, Northern Trust, Novo Nordisk & NXP Semi
Apr-30-15 06:50PM  Gilead EPS Spikes On Harvoni Drug, Latest HCV Fighter
10:48AM  Teva, Celgene, Novo Nordisk, Shire Report Q1 Earnings at Investor's Business Daily
07:08AM  European drugmakers lifted by weak euro at Financial Times
Apr-22-15 11:44AM  Economic Sentiment up in the Eurozone: EWG up 0.88%, FEZ up 0.46%
11:27AM  Novo launches Saxenda in US, sees more launches in 2015 Reuters
10:38AM  Novo Nordisk says Saxenda obesity drug to cost $1,068 per month
09:23AM  3 Large-Cap Pharmaceutical Companies to Invest in Right Now at TheStreet
Apr-13-15 05:09PM  Arena, Eisai Finish Phase I Studies on Obesity Drug Belviq - Analyst Blog
Apr-09-15 01:40PM  Novo Nordisk's Tresiba & Ryzodeg NDAs under FDA Review - Analyst Blog
Apr-01-15 02:46PM  Hedge Funds Made A Bundle By Betting On, Inc. (AMZN), Apple, and Pfizer Inc at Insider Monkey
10:40AM  FDA Urged to Fine Drugmakers Over Ads at Fox Business
08:01AM  Novo Nordisk A/S: Status regarding Novo Nordisk's holding of its own shares (31 March 2015) Globe Newswire Europe
Mar-31-15 03:43PM  Top First Quarter European ETFs
Mar-30-15 07:00AM  The Best and Worst Medalists of 2015's First Quarter at Morningstar
Mar-29-15 06:17PM  Novo Nordisks Insulin Move Is Right Medicine at The Wall Street Journal
Mar-27-15 11:39PM  Colgate-Palmolive Company (CL), Novo Nordisk A/S (ADR) (NVO) Among Billionaire Jim Simons Holdings for Long-Run at Insider Monkey
06:15PM  Novo Nordisk to Submit Interim DEVOTE Data to the FDA - Analyst Blog
03:10PM  Orexigen's Obesity Drug Mysimba Gains European Approval - Analyst Blog
02:18PM  Insulin: moving the needle at Financial Times
01:15PM  European stocks snap win streak; DAX logs first weekly loss in 2 months at MarketWatch
11:19AM  Sanofi to launch Toujeo diabetes drug in U.S. on Monday -source Reuters
11:06AM  European shares set for 2015's biggest weekly fall despite Novo Nordisk surge Reuters
09:40AM  Novo Nordisk's Insulin Move Is Right Medicine at The Wall Street Journal
08:13AM  Can The Uptrend Continue for Novo Nordisk (NVO)? - Tale of the Tape
07:39AM  Novo Nordisk surge buoys European shares after two-day slide Reuters
07:39AM  March 27 Premarket Briefing: 10 Things You Should Know
07:25AM  Cruise news you can use, plus more Friday business headlines at
06:10AM  European Stocks Rebound From Two-Day Drop
04:41AM  Novo Nordisk Soars on Plan to Resubmit Rejected Insulin in U.S. at Bloomberg
Mar-26-15 06:49PM  Novo Nordisk's Onset 1 & Onset 2 Meet Primary Objectives - Analyst Blog +6.90%
06:40PM  Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog
06:36PM  Red Hat, Signet Top Buy Points En Route To New Highs at Investor's Business Daily
04:01PM  Novo Nordisk (NVO) Stock Gains Today on Drug Application Resubmission at TheStreet
01:57PM  Novo Nordisk to Refile Tresiba in the U.S. on Interim Analysis at Bloomberg
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.